KMC Speciality Hospitals (India) Limited reported a 118% year-on-year increase in net profit to ₹4,673.44 lakh for the financial year ended March 31, 2026. Revenue from operations rose 32% to ₹30,576.82 lakh during the same period, driven by growth across its medical and healthcare services segment. The Board of Directors approved the standalone audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹1,463.04 lakh, compared to ₹452.20 lakh in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹8,225.31 lakh, up from ₹6,093.48 lakh in the same quarter of the previous year. Total income for the full year increased to ₹31,084.41 lakh from ₹23,468.40 lakh in the previous year.

Financial Performance

The following table summarises the company's annual standalone financial performance:

Q4 Operational Highlights

KMC Speciality Hospitals delivered a strong quarterly performance, with key profitability metrics showing significant improvement on a year-on-year basis. EBITDA for the quarter came in at ₹259 million versus ₹154 million in the same period of the previous year, while the EBITDA margin expanded notably to 31.46% from 25.30% year-on-year. The table below captures the key Q4 metrics:

Audit and Compliance

The statutory auditors, Deloitte Haskins & Sells, issued an unmodified opinion on the audited financial results for the year ended March 31, 2026. The auditors also reviewed the unaudited financial results for the quarter ended March 31, 2026, and concluded that no material misstatements were identified. The filing was submitted pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company's cash and cash equivalents as of March 31, 2026, stood at ₹5,002.07 lakh, a significant increase from ₹919.04 lakh in the previous year. This rise was primarily due to net cash generated from operating activities, which amounted to ₹7,909.92 lakh for FY26. The Board Meeting commenced at 10:30 AM and concluded at 11:35 AM on May 29, 2026.

KMC Specialty Hospitals (India) Limited has formally notified BSE Limited that it does not qualify as a 'Large Corporate' entity as on March 31, 2026, thereby exempting it from specific SEBI disclosure requirements for the financial year 2025-26.

Regulatory Compliance Declaration

The company submitted its initial disclosure on April 17, 2026, in compliance with SEBI regulations. The declaration was made pursuant to two key SEBI circulars that establish the framework for Large Corporate criteria and associated disclosure requirements.

SEBI Circular Framework

The disclosure was made in accordance with specific SEBI circulars that govern Large Corporate classification and reporting requirements. The regulatory framework is established through SEBI Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, which was updated on April 13, 2022, and read in conjunction with SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023.

Compliance Impact

Based on the company's confirmation of its non-Large Corporate status, the disclosure requirements specified in the aforementioned SEBI circulars are not applicable to KMC Specialty Hospitals (India) Limited for the financial year ended March 31, 2026. This classification affects the company's regulatory reporting obligations and compliance framework.

Corporate Information

The disclosure was signed by Indumathi P, Company Secretary & Compliance Officer, and submitted to BSE Limited's Corporate Relationship Department. The company operates from its registered office located at 6, Royal Road, Cantonment, Trichy - 620 001, and maintains NABL accreditation for its healthcare services.